Crossmark Global Holdings’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.84M | Sell |
34,792
-292
| -0.8% | -$68.1K | 0.11% | 179 |
|
|
2026
Q1 | $8.58M | Sell |
35,084
-1,305
| -4% | -$304K | 0.13% | 176 |
|
|
2025
Q4 | $7.53M | Sell |
36,389
-5,525
| -13% | -$1.09M | 0.11% | 194 |
|
|
2025
Q3 | $7.77M | Buy |
41,914
+126
| +0.3% | +$21.6K | 0.12% | 193 |
|
|
2025
Q2 | $6.38M | Sell |
41,788
-524
| -1% | -$80.5K | 0.1% | 218 |
|
|
2025
Q1 | $7.02M | Buy |
42,312
+3,625
| +9% | +$567K | 0.12% | 197 |
|
|
2024
Q4 | $5.59M | Sell |
38,687
-32
| -0.1% | -$4.96K | 0.1% | 216 |
|
|
2024
Q3 | $6.28M | Sell |
38,719
-1,884
| -5% | -$300K | 0.11% | 215 |
|
|
2024
Q2 | $5.93M | Buy |
40,603
+807
| +2% | +$120K | 0.11% | 210 |
|
|
2024
Q1 | $6.29M | Sell |
39,796
-1,471
| -4% | -$234K | 0.12% | 196 |
|
|
2023
Q4 | $6.47M | Sell |
41,267
-548
| -1% | -$84K | 0.13% | 181 |
|
|
2023
Q3 | $6.62M | Sell |
41,815
-3,272
| -7% | -$540K | 0.15% | 170 |
|
|
2023
Q2 | $7.87M | Buy |
45,087
+2,665
| +6% | +$430K | 0.17% | 159 |
|
|
2023
Q1 | $6.58M | Sell |
42,422
-6,444
| -13% | -$1.04M | 0.15% | 172 |
|
|
2022
Q4 | $8.63M | Sell |
48,866
-1,341
| -3% | -$232K | 0.22% | 128 |
|
|
2022
Q3 | $8.2M | Buy |
50,207
+1,867
| +4% | +$316K | 0.23% | 112 |
|
|
2022
Q2 | $8.58M | Sell |
48,340
-1,237
| -2% | -$220K | 0.22% | 116 |
|
|
2022
Q1 | $8.79M | Sell |
49,577
-781
| -2% | -$133K | 0.2% | 131 |
|
|
2021
Q4 | $8.62M | Sell |
50,358
-1,092
| -2% | -$179K | 0.19% | 136 |
|
|
2021
Q3 | $8.31M | Buy |
51,450
+1,885
| +4% | +$322K | 0.19% | 132 |
|
|
2021
Q2 | $8.16M | Sell |
49,565
-6,967
| -12% | -$1.15M | 0.19% | 132 |
|
|
2021
Q1 | $9.29M | Buy |
56,532
+1,037
| +2% | +$168K | 0.23% | 109 |
|
|
2020
Q4 | $8.73M | Sell |
55,495
-1,517
| -3% | -$224K | 0.22% | 112 |
|
|
2020
Q3 | $8.49M | Sell |
57,012
-1,858
| -3% | -$275K | 0.24% | 109 |
|
|
2020
Q2 | $8.28M | Buy |
58,870
+1,010
| +2% | +$147K | 0.24% | 101 |
|
|
2020
Q1 | $7.59M | Sell |
57,860
-1,087
| -2% | -$154K | 0.27% | 100 |
|
|
2019
Q4 | $8.6M | Sell |
58,947
-284
| -0.5% | -$38.5K | 0.24% | 114 |
|
|
2019
Q3 | $7.66M | Sell |
59,231
-11,279
| -16% | -$1.49M | 0.22% | 117 |
|
|
2019
Q2 | $9.82M | Sell |
70,510
-15
| -0% | -$2.08K | 0.28% | 88 |
|
|
2019
Q1 | $9.86M | Sell |
70,525
-1,454
| -2% | -$195K | 0.28% | 87 |
|
|
2018
Q4 | $9.29M | Buy |
71,979
+2,276
| +3% | +$317K | 0.29% | 81 |
|
|
2018
Q3 | $9.63M | Buy |
69,703
+3,485
| +5% | +$463K | 0.24% | 100 |
|
|
2018
Q2 | $8.04M | Sell |
66,218
-10,242
| -13% | -$1.28M | 0.22% | 121 |
|
|
2018
Q1 | $9.8M | Sell |
76,460
-2,602
| -3% | -$352K | 0.25% | 95 |
|
|
2017
Q4 | $11M | Sell |
79,062
-2,734
| -3% | -$381K | 0.27% | 87 |
|
|
2017
Q3 | $10.6M | Buy |
+81,796
| New | +$10.8M | 0.27% | 85 |
|
|
2016
Q3 | $10.6M | Buy |
+81,796
| New | +$9.92M | 0.27% | 85 |
|
Other funds holding JNJ
PAM
WT
CGI
Crossmark Global Holdings's JNJ Position: Q2 2026 in Review
Crossmark Global Holdings reduced its Johnson & Johnson (JNJ) stake by 0.83% in Q2 2026, selling an estimated $68.1K and leaving 34,792 shares worth $8.84M. The position accounts for 0.11% of the portfolio, ranked #179.
Crossmark Global Holdings first reported a position in JNJ in Q3 2016 and has held it in 37 quarters since. The position peaked at $11M in Q4 2017. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Crossmark Global Holdings held 34,792 shares of Johnson & Johnson worth $8.84M as of Q2 2026.
- Crossmark Global Holdings sold 292 Johnson & Johnson shares in Q2 2026, an estimated $68.1K.
- Johnson & Johnson made up 0.11% of Crossmark Global Holdings's portfolio in Q2 2026, its #179 holding.
- Crossmark Global Holdings first reported a position in Johnson & Johnson in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Johnson & Johnson position peaked at $11M in Q4 2017.
- 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.